# Study for Evaluation of Safety and Efficacy of PADN to Treat Combined Post- and Pre- Capillary Pulmonary Hypertension Associated With Chronic Heart Failure（PADN-CpcPH-PILOT）

> **NCT05996562** · NA · COMPLETED · sponsor: **Pulnovo Medical (Wuxi) Co., Ltd.** · enrollment: 30 (actual)

## Conditions studied

- Pulmonary Hypertension
- Heart Failure

## Interventions

- **PROCEDURE:** Pulmonary Artery Denervation

## Key facts

- **NCT ID:** NCT05996562
- **Lead sponsor:** Pulnovo Medical (Wuxi) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-28
- **Primary completion:** 2026-01-15
- **Final completion:** 2026-01-15
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05996562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05996562, "Study for Evaluation of Safety and Efficacy of PADN to Treat Combined Post- and Pre- Capillary Pulmonary Hypertension Associated With Chronic Heart Failure（PADN-CpcPH-PILOT）". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT05996562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*